These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 25464139)

  • 21. Susceptibility testing of anaerobic bacteria.
    Finegold SM
    J Clin Microbiol; 1988 Jul; 26(7):1253-6. PubMed ID: 3045147
    [No Abstract]   [Full Text] [Related]  

  • 22. In-vitro susceptibility of anaerobic bacteria to GAR-936, a new glycylcycline.
    Edlund C; Nord CE
    Clin Microbiol Infect; 2000 Mar; 6(3):159-63. PubMed ID: 11168096
    [No Abstract]   [Full Text] [Related]  

  • 23. Antimicrobial susceptibility of clinically isolated anaerobic bacteria in a University Hospital Centre Split, Croatia in 2013.
    Novak A; Rubic Z; Dogas V; Goic-Barisic I; Radic M; Tonkic M
    Anaerobe; 2015 Feb; 31():31-6. PubMed ID: 25479237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011.
    Marchand-Austin A; Rawte P; Toye B; Jamieson FB; Farrell DJ; Patel SN
    Anaerobe; 2014 Aug; 28():120-5. PubMed ID: 24923267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anaerobic infections--the most important antimicrobial drugs and their clinical profile.
    Solberg CO
    Scand J Gastroenterol Suppl; 1983; 85():14-22. PubMed ID: 6353550
    [No Abstract]   [Full Text] [Related]  

  • 26. [Sporeless anaerobic bacteria with special reference to resistance testing and resistance behavior].
    Wolter M
    Z Arztl Fortbild (Jena); 1983; 77(22):919-23. PubMed ID: 6362224
    [No Abstract]   [Full Text] [Related]  

  • 27. [Identification of anaerobic bacteria isolated from various clinical specimens and determination of antibiotic susceptibilities].
    Doğan M; Baysal B
    Mikrobiyol Bul; 2010 Apr; 44(2):211-9. PubMed ID: 20549955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anaerobic microbiology: time to rejuvenate.
    Bharadwaj R
    Indian J Med Microbiol; 2012; 30(1):3-5. PubMed ID: 22361753
    [No Abstract]   [Full Text] [Related]  

  • 29. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
    Shore KP; Pottumarthy S; Morris AJ
    N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Specificity of the anaerobic bacterial infections in the surgical and orthopedic wards].
    Kierzkowska M; Majewska A; Sawicka-Grzelak A; Młynarczyk A; Ładomirska-Pestkowska K; Młynarczyk G
    Med Dosw Mikrobiol; 2012; 64(1):29-34. PubMed ID: 22808727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial resistance: action by laboratories today for a cure tomorrow.
    Kanungo R
    Indian J Med Microbiol; 2011; 29(3):205-6. PubMed ID: 21860096
    [No Abstract]   [Full Text] [Related]  

  • 32. Surveillance and trends of antimicrobial resistance among clinical isolates of anaerobes in Kuwait hospitals from 2002 to 2007.
    Jamal W; Shahin M; Rotimi VO
    Anaerobe; 2010 Feb; 16(1):1-5. PubMed ID: 19406247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chapter 1-1. Anaerobic infections (General): epidemiology of anaerobic infections.
    ;
    J Infect Chemother; 2011 Jul; 17 Suppl 1():4-12. PubMed ID: 21728084
    [No Abstract]   [Full Text] [Related]  

  • 34. Correlation between antibiotic resistance and clinical outcome of anaerobic infections; mini-review.
    Dubreuil L; Veloo AC; Sóki J;
    Anaerobe; 2021 Dec; 72():102463. PubMed ID: 34597797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New data, established in vitro and in vivo, on the sensitivity of anaerobic bacteria to antibiotics].
    Bittner J; Antohi M; Ardeleanu J; Munteanu V; Lemeni D; Macovei A
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1987; 32(1):11-22. PubMed ID: 3589387
    [No Abstract]   [Full Text] [Related]  

  • 36. Incidence and role of anaerobic flora in local and systemic infections in childhood.
    Bittner J; Munteanu V; Ardeleanu J; Antohi M; Macovei A; Lemeni D; Gheorghe V; Popescu A; Popescu E; Ciucă T
    Arch Roum Pathol Exp Microbiol; 1988; 47(2):93-7. PubMed ID: 3250368
    [No Abstract]   [Full Text] [Related]  

  • 37. [Infections by anaerobes in children: frequency of isolation and antimicrobial resistance].
    Leaños B; Guiscafré H; Guerra R; Sandoval M; Rubí S; Trejo JA; Zúñiga V
    Bol Med Hosp Infant Mex; 1989 Jul; 46(7):455-62. PubMed ID: 2788434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different breakpoints interpretation yielded distinct resistance rates to moxifloxacin of clinically significant anaerobic bacteria.
    Cobo F; Sadyrbaeva-Dolgova S; Navarro-Marí JM
    Anaerobe; 2021 Dec; 72():102471. PubMed ID: 34715325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harmonization of antimicrobial susceptibility testing breakpoints in Europe: implications for reporting intermediate susceptibility.
    Brown D; Macgowan A
    J Antimicrob Chemother; 2010 Feb; 65(2):183-5. PubMed ID: 19996143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic resistance: understanding how to control it.
    Gould IM
    Int J Antimicrob Agents; 2012 Sep; 40(3):193-5. PubMed ID: 22824370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.